IS2742B - Samsetning@sem@nær@yfir@basískan@svingómýelínasa@af@bakteríuuppruna@til@nota@sem@næringarfræðileg@efnablanda@@fæðubótarefni@eða@lyfjaafurð - Google Patents

Samsetning@sem@nær@yfir@basískan@svingómýelínasa@af@bakteríuuppruna@til@nota@sem@næringarfræðileg@efnablanda@@fæðubótarefni@eða@lyfjaafurð

Info

Publication number
IS2742B
IS2742B IS6178A IS6178A IS2742B IS 2742 B IS2742 B IS 2742B IS 6178 A IS6178 A IS 6178A IS 6178 A IS6178 A IS 6178A IS 2742 B IS2742 B IS 2742B
Authority
IS
Iceland
Prior art keywords
composition
sphingomyelinase
covers
basic
pharmaceutical product
Prior art date
Application number
IS6178A
Other languages
English (en)
Other versions
IS6178A (is
Inventor
Claudio De Simone
Original Assignee
Actial Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2742(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actial Farmaceutica Lda filed Critical Actial Farmaceutica Lda
Publication of IS6178A publication Critical patent/IS6178A/is
Publication of IS2742B publication Critical patent/IS2742B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04012—Sphingomyelin phosphodiesterase (3.1.4.12)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
IS6178A 1999-06-09 2001-11-27 Samsetning@sem@nær@yfir@basískan@svingómýelínasa@af@bakteríuuppruna@til@nota@sem@næringarfræðileg@efnablanda@@fæðubótarefni@eða@lyfjaafurð IS2742B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000376A IT1311495B1 (it) 1999-06-09 1999-06-09 Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
PCT/IT2000/000230 WO2000074712A2 (en) 1999-06-09 2000-06-07 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product

Publications (2)

Publication Number Publication Date
IS6178A IS6178A (is) 2001-11-27
IS2742B true IS2742B (is) 2011-06-15

Family

ID=11406823

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6178A IS2742B (is) 1999-06-09 2001-11-27 Samsetning@sem@nær@yfir@basískan@svingómýelínasa@af@bakteríuuppruna@til@nota@sem@næringarfræðileg@efnablanda@@fæðubótarefni@eða@lyfjaafurð

Country Status (34)

Country Link
US (2) US20020031507A1 (is)
EP (1) EP1181047B9 (is)
JP (2) JP4897167B2 (is)
KR (1) KR100812806B1 (is)
CN (3) CN101695374B (is)
AR (1) AR024564A1 (is)
AT (1) ATE237350T1 (is)
AU (1) AU778946B2 (is)
BR (1) BR0011447A (is)
CA (1) CA2376048C (is)
CZ (1) CZ296369B6 (is)
DE (1) DE60002194T3 (is)
DK (1) DK1181047T4 (is)
DZ (1) DZ3160A1 (is)
EA (1) EA005166B1 (is)
EE (1) EE05491B1 (is)
EG (1) EG24675A (is)
ES (1) ES2195902T5 (is)
HK (1) HK1046246A1 (is)
HU (1) HU228941B1 (is)
IL (2) IL146888A0 (is)
IS (1) IS2742B (is)
IT (1) IT1311495B1 (is)
MA (1) MA26792A1 (is)
MX (1) MXPA01012641A (is)
NO (1) NO327862B1 (is)
PL (1) PL214675B1 (is)
PT (1) PT1181047E (is)
SI (1) SI1181047T2 (is)
SK (1) SK285901B6 (is)
TR (1) TR200103566T2 (is)
UA (1) UA80799C2 (is)
WO (1) WO2000074712A2 (is)
ZA (1) ZA200200039B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
IE20011100A1 (en) * 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
US9980988B2 (en) 2002-03-13 2018-05-29 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
KR100568036B1 (ko) * 2004-08-12 2006-04-07 하남주 장기능 활성화 및 면역기능 강화작용을 하는비피도박테리움 균주 및 이를 함유하는 생균제제
KR100610379B1 (ko) * 2004-08-26 2006-08-10 하남주 면역 증강 활성을 가지는 신규 유산균
TW200837194A (en) * 2007-03-06 2008-09-16 Microbio Company Ltd Taiwan Fermented panax notoginseng solution with anti-cancer effects and manufacture method thereof
KR100868777B1 (ko) * 2007-03-15 2008-11-17 재단법인서울대학교산학협력재단 Ｒｓ３ 유형의 저항 전분에 대해 분해능이 있는비피도박테리움 아도레스센티스를 유효성분으로 함유하는것을 특징으로 하는 식품 조성물
WO2009130349A1 (es) 2008-04-22 2009-10-29 Corporación Alimentaria Peñasanta (Capsa) Obtención de una nueva cepa de bifidobacterium bifidum con actividad frente a la infección por helicobacter pylori
ES2395529B1 (es) 2011-06-08 2014-04-11 Pri, S.A. Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
KR101364695B1 (ko) * 2011-06-29 2014-02-19 가천대학교 산학협력단 헬리코박터 파이로리의 생육을 저해하는 타락 유래 젖산균
MX2015005165A (es) * 2012-10-25 2015-10-29 Gervais Danone Sa Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori.
KR101479818B1 (ko) * 2012-12-17 2015-01-26 주식회사 알엔에이 유산균 파쇄물의 제조방법
TW201630596A (zh) * 2015-01-06 2016-09-01 Meiji Co Ltd 鞘脂質吸收促進劑
CN109069555B (zh) * 2016-04-13 2022-07-26 株式会社明治 面向新生儿的用于改善脑功能的组合物
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55120787A (en) * 1979-03-09 1980-09-17 Teruhiko Beppu Preparation of sphingomyelinase
JPS60221084A (ja) * 1984-04-18 1985-11-05 Chiyoda Chem Eng & Constr Co Ltd スフインゴミエリナ−ゼの製造法
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP2676484B2 (ja) * 1994-03-28 1997-11-17 熊本県 ヨーグルト様乳酸発酵食品の製造方法
JP3122333B2 (ja) * 1995-02-28 2001-01-09 株式会社薬理学中央研究所 赤血球を原料とするスフィンゴミエリンおよびセラミドの新規製造方法とセラミド配合治療剤又は化粧品
JP4021951B2 (ja) * 1996-03-01 2007-12-12 わかもと製薬株式会社 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品
JP3530674B2 (ja) * 1996-03-04 2004-05-24 明治乳業株式会社 変異原性物質吸収阻害性食品
IT1288119B1 (it) * 1996-06-28 1998-09-10 Renata Maria Anna Ve Cavaliere Composizioni dietetiche da utilizzare nell'alimentazione per via enterica
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
JP3400282B2 (ja) * 1997-02-21 2003-04-28 株式会社ヤクルト本社 脂質代謝改善剤およびそれを含有する食品
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.

Also Published As

Publication number Publication date
IL146888A0 (en) 2002-08-14
CZ296369B6 (cs) 2006-02-15
TR200103566T2 (tr) 2002-05-21
HU228941B1 (en) 2013-07-29
ZA200200039B (en) 2002-12-24
PL214675B1 (pl) 2013-09-30
DE60002194D1 (de) 2003-05-22
SI1181047T2 (sl) 2010-02-26
NO327862B1 (no) 2009-10-05
DK1181047T4 (da) 2010-03-15
EA200200019A1 (ru) 2002-06-27
EA005166B1 (ru) 2004-12-30
EP1181047B9 (en) 2010-08-25
DE60002194T3 (de) 2010-02-25
CZ20014219A3 (cs) 2002-04-17
AU778946B2 (en) 2004-12-23
DZ3160A1 (fr) 2000-12-14
CN101352234A (zh) 2009-01-28
BR0011447A (pt) 2002-03-19
MXPA01012641A (es) 2004-03-19
PL364729A1 (en) 2004-12-13
NO20016004D0 (no) 2001-12-07
SK17162001A3 (sk) 2002-03-05
CN101695374A (zh) 2010-04-21
AR024564A1 (es) 2002-10-16
SK285901B6 (sk) 2007-10-04
UA80799C2 (uk) 2007-11-12
CN101695374B (zh) 2015-08-19
CA2376048A1 (en) 2000-12-14
DE60002194T2 (de) 2004-01-29
US20020031507A1 (en) 2002-03-14
HUP0201631A3 (en) 2006-02-28
EP1181047B1 (en) 2003-04-16
HUP0201631A2 (hu) 2005-12-28
WO2000074712A2 (en) 2000-12-14
ATE237350T1 (de) 2003-05-15
DK1181047T3 (da) 2003-08-11
ITRM990376A0 (it) 1999-06-09
EP1181047A2 (en) 2002-02-27
MA26792A1 (fr) 2004-12-20
IS6178A (is) 2001-11-27
US20050084486A1 (en) 2005-04-21
JP4897167B2 (ja) 2012-03-14
JP2003501399A (ja) 2003-01-14
CA2376048C (en) 2014-12-09
PT1181047E (pt) 2003-09-30
ES2195902T9 (es) 2011-03-01
AU5563900A (en) 2000-12-28
CN1354672A (zh) 2002-06-19
JP2012040015A (ja) 2012-03-01
ITRM990376A1 (it) 2000-12-09
ES2195902T5 (es) 2010-02-18
EG24675A (en) 2010-04-27
WO2000074712A3 (en) 2001-05-03
KR100812806B1 (ko) 2008-03-12
IT1311495B1 (it) 2002-03-13
EE200100661A (et) 2003-04-15
EP1181047B2 (en) 2009-10-28
EE05491B1 (et) 2011-12-15
NO20016004L (no) 2002-02-06
ES2195902T3 (es) 2003-12-16
KR20020016826A (ko) 2002-03-06
IL146888A (en) 2012-02-29
SI1181047T1 (en) 2003-10-31
HK1046246A1 (zh) 2003-01-03

Similar Documents

Publication Publication Date Title
IS2742B (is) Samsetning@sem@nær@yfir@basískan@svingómýelínasa@af@bakteríuuppruna@til@nota@sem@næringarfræðileg@efnablanda@@fæðubótarefni@eða@lyfjaafurð
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
IL134731A0 (en) Methods of treating capsules and dry, powdered pharmaceutical formulations
WO2002083879A3 (en) Immunotherapy based on dendritic cells
WO2001041785A3 (en) Enzyme treatment for infection
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
IL161995A (en) Purified strain of lactic acid bacterium and uses thereof in the preparation of edible compositions, drugs and veterinary products
WO2003051345A3 (de) Verwendung von verdauungsenzymgemischen zur behandlung pathologischer bakterieller überwucherung des dünndarms von säugetieren und menschen
DK0942741T3 (da) Lektinpræparater og anvendelser deraf
CA2335308A1 (en) Protease containing hairball remedy and use thereof
EP1219630A4 (en) Immune-strengthening compounds
NO20013787D0 (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
WO2001089317A3 (en) Dietary aids and methods of use thereof
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
CA2343116A1 (en) Methods and compositions for increasing intestinal absorption of fats
WO2008075333A3 (en) Edible compositions for preventing hair loss
ATE238034T1 (de) Geschmacksmaskierung schlecht schmeckender formulierungen
DE69902879D1 (de) Pflanzliches antivirales mittel
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
RU98105720A (ru) Биологически активная добавка для лечебных и косметических средств
RU2000104127A (ru) Штамм bacillus subtilis x-15, используемый для профилактики и лечения эндометритов у коров
SI1494692T1 (sl) Topikalni farmacevtski sestavki, ki obsegajo proantocianide, gliciretinsko kislino in telmestein, za zdravljenje dermatitisa